Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin.
about
Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Complete response in a critica ...... gle agent brentuximab-vedotin.
@en
Complete response in a critica ...... gle agent brentuximab-vedotin.
@nl
type
label
Complete response in a critica ...... gle agent brentuximab-vedotin.
@en
Complete response in a critica ...... gle agent brentuximab-vedotin.
@nl
prefLabel
Complete response in a critica ...... gle agent brentuximab-vedotin.
@en
Complete response in a critica ...... gle agent brentuximab-vedotin.
@nl
P2093
P2860
P1476
Complete response in a critica ...... gle agent brentuximab-vedotin.
@en
P2093
Emily Everett
Gayathri Nagaraj
Karlos Z Oregel
Xinhai Zhang
P2860
P304
P356
10.1586/14737140.2016.1146597
P577
2016-01-25T00:00:00Z